1-9 of 9
Maha Ayyoub
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1059: Biomarkers analysis on samples from patients in EVT801 clinical trial: Patient characterization and immunomonitoring

Lise Davenne, Michael Fitzgerald, Pierre-Benoit Ancey, Oona Delpuech, Céline Poussereau-Pomié, Michael Esquerre, Michael R. Paillasse, Marie Mandron, Philippe Rochaix, Maha Ayyoub, Clara Maria Scarlata, Christine Caux, Christophe Caux, Philippe Cassier, Carlos Gomez-Roca, Jean-Pierre Delord, John Friend, Pierre Fons
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 1059.
https://doi.org/10.1158/1538-7445.AM2024-1059
Published: 22 March 2024
View article titled, Abstract 1059: Biomarkers analysis on samples from patients in EVT801 clinical trial: Patient characterization and immunomonitoring
Journal Articles

Abstract A076: T-cell exhaustion is an independent predictive biomarker of clinical outcome in high grade serous ovarian cancer regardless of homologous recombination deficiency status

Anna Salvioni, Mathilde Del, Marie Michelas, Pierre Vuattoux, Clara-Maria Scarlata, Carlos Martinez-Gomez, Nathalie Van Acker, François-Xavier Frenois, Guillaume Bataillon, Jean-Pierre Delord, Alejandra Martinez, Maha Ayyoub
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): A076.
https://doi.org/10.1158/1538-7445.OVARIAN23-A076
Published: 04 March 2024
View article titled, Abstract A076: T-cell exhaustion is an independent predictive biomarker of clinical outcome in high grade serous ovarian cancer regardless of homologous recombination deficiency status
Journal Articles

Abstract 3203: Cutting edge biomarkers strategy to provide early insights into activity of EVT-801, a novel selective VEGFR-3 inhibitor that targets tumor angiogenesis during the FIH clinical trial

Michael R. Paillasse, James Garner, Michael Fitzgerald, Lise Davenne, Pierre-Benoit Ancey, celine Poussereau-Pomie, Michael Esquerre, Gaelle Badet, Joel Tuyaret, Marie Mandron, Philippe Rochaix, Maha Ayyoub, Clara Maria Scarlata, Christine Ménétrier-Caux, Chrsitophe CAUX, Philippe Cassier, Jean-Pierre Delord, Carlos Gomez Roca, Pierre Fons
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 3203.
https://doi.org/10.1158/1538-7445.AM2022-3203
Published: 15 June 2022
View article titled, Abstract 3203: Cutting edge biomarkers strategy to provide early insights into activity of EVT-801, a novel selective VEGFR-3 inhibitor that targets tumor angiogenesis during the FIH clinical trial
Journal Articles

Regulation of CD4+NKG2D+ Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15Rα and NKG2D Triggering

Ana I. Romero, Nathalie Chaput, Vichnou Poirier-Colame, Sylvie Rusakiewicz, Nicolas Jacquelot, Kariman Chaba, Erwan Mortier, Yannick Jacques, Sophie Caillat-Zucman, Caroline Flament, Anne Caignard, Meriem Messaoudene, Anne Aupérin, Philippe Vielh, Philippe Dessen, Camillo Porta, Christine Mateus, Maha Ayyoub, Danila Valmori, Alexander Eggermont, Caroline Robert, Laurence Zitvogel
Journal: Cancer Research
Cancer Res (2014) 74 (1): 68–80.
https://doi.org/10.1158/0008-5472.CAN-13-1186
Published: 05 January 2014
View article titled, Regulation of CD4<sup>+</sup>NKG2D<sup>+</sup> Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15Rα and NKG2D Triggering
Open the PDF for Regulation of CD4<sup>+</sup>NKG2D<sup>+</sup> Th1 Cells in Patients with Metastatic Melanoma Treated with Sorafenib: Role of IL-15Rα and NKG2D Triggering in another window
Includes: Supplementary data
Journal Articles

CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity

Nassima Redjimi, Caroline Raffin, Isabelle Raimbaud, Pascale Pignon, Junko Matsuzaki, Kunle Odunsi, Danila Valmori, Maha Ayyoub
Journal: Cancer Research
Cancer Res (2012) 72 (17): 4351–4360.
https://doi.org/10.1158/0008-5472.CAN-12-0579
Published: 30 August 2012
View article titled, CXCR3<sup>+</sup> T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
Open the PDF for CXCR3<sup>+</sup> T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity in another window
Includes: Supplementary data
Journal Articles

Human TH17 Immune Cells Specific for the Tumor Antigen MAGE-A3 Convert to IFN-γ–Secreting Cells as They Differentiate into Effector T Cells In Vivo

Ahmed Hamaï, Pascale Pignon, Isabelle Raimbaud, Karine Duperrier-Amouriaux, Hélène Senellart, Sandrine Hiret, Jean-Yves Douillard, Jaafar Bennouna, Maha Ayyoub, Danila Valmori
Journal: Cancer Research
Cancer Res (2012) 72 (5): 1059–1063.
https://doi.org/10.1158/0008-5472.CAN-11-3432
Published: 01 March 2012
View article titled, Human T<sub>H</sub>17 Immune Cells Specific for the Tumor Antigen MAGE-A3 Convert to IFN-γ–Secreting Cells as They Differentiate into Effector T Cells <em>In Vivo</em>
Open the PDF for Human T<sub>H</sub>17 Immune Cells Specific for the Tumor Antigen MAGE-A3 Convert to IFN-γ–Secreting Cells as They Differentiate into Effector T Cells <em>In Vivo</em> in another window
Includes: Supplementary data
Journal Articles

Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer

Feng Qian, Jeannine Villella, Paul K. Wallace, Paulette Mhawech-Fauceglia, Joseph D. Tario, Jr., Christopher Andrews, Junko Matsuzaki, Danila Valmori, Maha Ayyoub, Peter J. Frederick, Amy Beck, Jianqun Liao, Richard Cheney, Kirsten Moysich, Shashikant Lele, Protul Shrikant, Lloyd J. Old, Kunle Odunsi
Journal: Cancer Research
Cancer Res (2009) 69 (13): 5498–5504.
https://doi.org/10.1158/0008-5472.CAN-08-2106
Published: 01 July 2009
View article titled, Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer
Open the PDF for Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Processing of Tumor-Associated Antigen by the Proteasomes of Dendritic Cells Controls In vivo T-Cell Responses

Laurence Chapatte, Maha Ayyoub, Sandra Morel, Anne-Lise Peitrequin, Nicole Lévy, Catherine Servis, Benoît J. Van den Eynde, Danila Valmori, Frédéric Lévy
Journal: Cancer Research
Cancer Res (2006) 66 (10): 5461–5468.
https://doi.org/10.1158/0008-5472.CAN-05-4310
Published: 16 May 2006
View article titled, Processing of Tumor-Associated Antigen by the Proteasomes of Dendritic Cells Controls <em>In vivo</em> T-Cell Responses
Open the PDF for Processing of Tumor-Associated Antigen by the Proteasomes of Dendritic Cells Controls <em>In vivo</em> T-Cell Responses in another window
Journal Articles

Tumor-reactive, SSX-2-specific CD8+ T Cells Are Selectively Expanded during Immune Responses to Antigen-expressing Tumors in Melanoma Patients

Maha Ayyoub, Donata Rimoldi, Philippe Guillaume, Pedro Romero, Jean-Charles Cerottini, Danila Valmori, Daniel Speiser
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5601–5606.
Published: 18 September 2003
View article titled, Tumor-reactive, SSX-2-specific CD8<sup>+</sup> T Cells Are Selectively Expanded during Immune Responses to Antigen-expressing Tumors in Melanoma Patients
Open the PDF for Tumor-reactive, SSX-2-specific CD8<sup>+</sup> T Cells Are Selectively Expanded during Immune Responses to Antigen-expressing Tumors in Melanoma Patients in another window